Abstract: A polarizing plate and an optical display apparatus including the same are disclosed. A polarizing plate includes: a polarizer; and a protective layer on at least one surface of the polarizer, and the polarizer includes a polyvinyl alcohol based film containing a dichroic material and contains a zinc cation and a sodium cation, and a ratio of the sodium cation to the zinc cation is in a range from 0.1 to 0.96, and a total content of the zinc cation and the sodium cation is in a range from 500 ppm to 1,500 ppm.

Abstract: A ligand compound represented by the following Formula 1, which shows high catalyst activity and high selectivity to 1-hexene and 1-octene, and may perform ethylene oligomerization with excellent efficiency, an organochromium compound, a catalyst composition comprising the organochromium compound and a method for oligomerizing ethylene using the same, are described: wherein all the variables are described herein.

Abstract: The present invention relates to a method for preparing a carbon nanotube-producing catalyst using chemical vapor deposition method. Using the above preparation method, a uniform and thin coating layer can be formed even on the surface of a support having a high-specific-surface-area having a 3D structure, and high-quality and low-diameter carbon nanotubes can be produced using the catalyst prepared through this method.

Abstract: The present invention relates to a catalyst for producing carbon nanotubes, a method for preparing the catalyst, and a method for producing carbon nanotubes using the catalyst which includes a support, and an active layer formed on a surface of the support, wherein the active layer contains CoO and Co3O4, and has, through XRD pattern measurement, one peak at 2?=35° to 38°, and one peak at 2?=41° to 44°, and a proportion of CoO among the CoO and Co3O4 is 55 at % or more. The catalyst according to the present invention can efficiently synthesize low-diameter carbon nanotubes.

Abstract: Provided are a piperidine derivative compound, a hydrate thereof, a solvate thereof, or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for the prevention or treatment of diseases related to autotaxin activity, comprising same as an active ingredient, in which the piperidine derivative compound exhibits excellent inhibitory activity against autotaxin, and thus can be effectively used in the treatment and prevention of diseases related to autotaxin inhibition, such as fibrotic diseases, inflammatory diseases, autoimmune diseases, respiratory diseases, cardiovascular diseases, metabolic diseases, cancer and cancer metastasis, ocular diseases, cholestatic form and other forms of chronic pruritus, and acute or chronic organ transplant rejection.

Abstract: The present invention relates to bundle-type carbon nanotubes having an average bundle thickness of 10 ?m or more, and a D50 of 10 ?m or more. The carbon nanotubes have excellent electrical conductivity and dispersibility and are particularly suitable for use as a conductive material.

Abstract: A display device includes first to third light emitting units disposed on a substrate, an encapsulation layer disposed on the first to third light emitting units, a sensor electrode disposed on the encapsulation layer, an insulating layer disposed on the sensor electrode, first to third color filters disposed on the touch insulating layer and overlapping the first to third light emitting units in a thickness direction of the substrate, respectively. The sensor electrode overlaps at least one of the first color filter, the second color filter, and the third color filter in the thickness direction of the substrate.

Abstract: A polarizing plate and an optical display apparatus including the same are disclosed. A polarizing plate includes: a polarizer; and an optical stack on a surface of the polarizer, the optical stack including an antiglare layer, and the polarizing plate has an external haze of greater than 30%, an internal haze of less than 10%, a 60 degree gloss of 10 GU or less, and a 60 degree gloss-to-85 degree gloss ratio (60 degree gloss/85 degree gloss) of 0.2 or less.

Abstract: The present disclosure relates to an optical laminate for a flexible display device comprising: a support substrate layer; and a hard coating layer positioned on at least one surface of the support substrate layer and having a thickness of 10 ?m to 250 ?m, wherein the hard coating layer is a polysiloxane containing 70 mol % or more of a repeating unit including an epoxy group-containing functional group; and an elastomeric polymer including polycaprolactone polyol, and wherein the polysiloxane has a number average molecular weight of more than 3,000 and less than 10,000, and a polydispersity Index (PDI) of 1.0 or more and less than 5.0, and a flexible display device including the same.

Abstract: The present invention pertains to an anticancer composition containing IF1 (ATPase inhibitory factor 1). The IF1 (ATPase inhibitory factor 1) according to the present invention has the effect of releasing extracellular ATP, induces cytotoxicity in various cancer cells and exhibits anticancer efficacy, and is thus very useful as an active ingredient of a powerful anticancer agent.

Abstract: A cholesterol measurement device includes a measuring instrument body; and a light-intensity check member mounted on and integrated with the measuring instrument body. The light intensity check member reflects light emitted from a light-emitting unit, allowing detecting abnormal light intensity and accurate assessing light intensity change, which prevents a measurement value change due to the change in light intensity and improves reliability of the measurement value. The device keeps a measurement unit clean all the time since the measurement unit can be easily cleaned by separating a strip fixation unit, when a specimen flows into the strip fixation unit in which a measurement strip is inserted.

Abstract: An organic light emitting diode (OLED) and an organic light emitting device (e.g., a display device or a lighting device) comprising the OLED are described. An emissive layer includes a red emitting material layer, a yellow-green emitting material layer and a green emitting material layer disposed sequentially between two electrodes, where each of the emitting material layers has controlled thickness and includes at least one host with controlled energy level. The OLED and the organic light emitting device have improved pure color luminous efficiency and color gamut, as well as luminous efficiency and luminous lifespan.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating inflammatory bowel disease acting as a functional antagonist for S1PR1 and S1PR4 of S1P receptors, and more specifically, to a pharmaceutical composition including, as an active ingredient, a sphingolipid compound which does not cause cardiovascular side effects by acting as a functional antagonist for S1PR1 and S1PR4 and has an effect of preventing or treating inflammatory bowel disease.

Abstract: The present invention relates to a pharmaceutical composition which is for preventing or treating obesity, and comprises a biglycan as an active ingredient. Biglycan according to the present invention suppresses appetite by decreasing the expression of Agrp and NPY, which are appetite promoting peptides, and increasing the expression of POMC, which is an appetite suppressing peptide, and thus is very useful as a medicine for treating obesity.

Abstract: The present invention provides antisense oligonucleotides for the treatment of various T-type calcium channel ?1G subunit-related disorders, and more specifically, antisense oligonucleotides for inhibiting expression of the gene encoding Cav3.1, targeting SEQ ID NO: 1, for the treatment of various neuropsychiatric disorders, including Parkinson's disease, epilepsy, essential tremor, depression, anxiety disorders, and unconsciousness.

Abstract: The present disclosure provides mimic molecules that are capable of specifically targeting a FAM19A5 protein, and thereby, inhibiting, reducing, and/or dissociating the interaction between members of the LRRC4 protein family and the FAM19A5 protein. The present disclosure also provides methods for promoting neurite outgrowth, by administering a mimic molecule described herein.

Abstract: An organic light emitting diode (OLED) and an organic light emitting device comprising the OLED are described. The OLED can comprise a first electrode; a second electrode facing the first electrode; and a first emitting part (including a first blue emitting layer and a second blue emitting layer), which is positioned between the first and second electrode. The second blue emitting layer is positioned between the first blue emitting layer and the second electrode and contacting the first blue emitting layer. The first blue emitting layer includes a first host and a first dopant, and the second blue emitting layer includes a second host and a second dopant, wherein the first host is a pyrene derivative, and the second host is an anthracene derivative. An organic light emitting device can include the OLED, and can be a display device or a lighting device.

Abstract: The present invention provides a battery module including: a pair of battery groups in which a plurality of battery cells are stacked; a first heat exchanger disposed between the pair of battery groups to perform heat exchange with first stacked surfaces of the pair of battery groups; and a pair of second heat exchangers disposed outside the pair of battery groups to perform heat exchange with second stacked surfaces which are sides opposite to the first stacked surfaces.

Abstract: Disclosed are a tandem catalyst for synthesizing methyl acetate from carbon dioxide, a method for preparing the same, and a method for preparing methyl acetate using the same. The tandem catalyst of the present invention includes a first catalyst having a core-shell structure including a composite metal oxide core and a silica shell surrounding a surface of the composite metal oxide core, and a second catalyst including nano-ferrierite (N-FER) zeolite.

Abstract: The present invention relates to a method for evaluating an efficacy of an anticancer drug or an anticancer drug candidate, comprising the step of treating a mixture of cancer organoids and immune cells with the anticancer drug or the anticancer drug candidate. In addition, it relates to the anticancer drug efficacy evaluation system or anticancer drug screening system comprising cancer organoids and immune cells. The mixture of cancer organoids and immune cells according to the present invention is mixed in a specific ratio, and accordingly can similarly reproduce a tumor microenvironment in which cancer cells exist in the body. Therefore, it can make it possible to accurately predict the efficacy of the drug when administered to a subject.